Drug Profile
Research programme: corticosteroid dry powder inhalation - Savara Pharmaceuticals
Alternative Names: AeroCortLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Savara Pharmaceuticals
- Class Corticosteroids
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Asthma(In children) in USA (Inhalation, Powder)
- 14 Jun 2012 Preclinical trials in Asthma in USA (Inhalation)